Search Results for "unrelated"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for unrelated. Results 1 to 3 of 3 total matches.
Omidubicel (Omisirge) for Neutrophil Recovery Following Myeloablative Conditioning Therapy (online only)
The Medical Letter on Drugs and Therapeutics • May 29, 2023 (Issue 1677)
, a cultured fraction and a noncultured
fraction, both derived from the same unrelated
patient-specific cord ...
The FDA has approved omidubicel-onlv (Omisirge –
Gamida Cell), a nicotinamide-modified, allogeneic
hematopoietic progenitor cell therapy derived from
cord blood, to reduce the time to neutrophil recovery
and the risk of infection in patients ≥12 years old
with hematologic malignancies who will undergo
umbilical cord blood transplantation following
myeloablative conditioning therapy. Hematopoietic
progenitor cell (HPC) umbilical cord products (e.g.,
Allocord, Clevecord, Ducord) have been available in
the US for years for the same indication. Cord blood
banks also supply cord...
Med Lett Drugs Ther. 2023 May 29;65(1677):e93-4 doi:10.58347/tml.2023.1677h | Show Introduction Hide Introduction
Fluvoxamine for COVID-19?
The Medical Letter on Drugs and Therapeutics • May 03, 2021 (Issue 1623)
is structurally
unrelated to other SSRIs. In addition to its serotoninmodulating
activity, it is a strong ...
A recent article in JAMA and an interview of its senior
author on 60 Minutes have heightened interest in
off-label use of the oral selective serotonin reuptake
inhibitor (SSRI) fluvoxamine (Luvox, and generics) to
treat COVID-19.
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
symptoms reported by statin users
are unrelated to the drugs
▶ Rhabdomyolysis and myoglobinemia leading ...
View the Comparison Table: Some Lipid-Lowering Drugs